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A new series of 30 miscellaneous National Toxicology Program chemicals has been evaluated
prospectively for carcinogenicity and overt toxicity by COMPACT (Computer Optimised Molecular
Parametric Analysis for Chemical Toxicity: CYPlA and CYP2E1). Evaluations were also made by
Hazardexpert, and for metal ion redox potentials; and these, together with COMPACT, were
compared with results from the Ames test for mutagenicity in Salmonella, the micronucleus test,
and 90-day subchronic rodent pathology. Seven of the 30 chemicals (nitromethane, chloroprene,
xylenesulfonic acid, furfuryl alchohol, anthraquinone, emodin, cinnamaldehyde) were positive for
potential carcinogenicity in the COMPACT evaluation; xylenesulphonic acid and furfuryl alchohol
were only equivocally positive. Four of the 30 chemicals-scopolamine, D&C Yellow No. 11,
citral, cinnamaldehyde-were positive by Hazardexpert; 6 of 30-D&C Yellow No. 11, 1-chloro-2-
propanol, anthraquinone, emodin, sodium nitrite, cinnamaldehyde-were positive in the Ames
test; 2 of 30-phenolphthalein and emodin-were positive in the in vivo cytogenetics test; and 3
of 30-molybdenum trioxide, gallium arsenide, vanadium pentoxide-were metal compounds
with redox potentials of the metal/metal ion indicative of possible carcinogenicity. The overall
prediction for carcinogenicity was positive for 12 of 30 chemicals: nitromethane, chloroprene,
D&C Yellow No. 11, molybdenum trioxide, 1-chloro-2-propanol, furfuryl alcohol, gallium arsenide,
anthraquinone, emodin, sodium nitrite, cinnamaldehyde, vanadium pentoxide). This overall
prediction has been made on the basis of the results of the computer tests and from consideration
of the information from bacterial mutagenicity, together with likely lipid solubility and pathways of
metabolism and elimination- Environ Health Perspect 104(Suppl 5):1011-1016 (1996)
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Introduction
The key to biological activity and toxicity
is inherent in the electronic structure of
the chemical. Computer optimised molec-
ular parametric analysis for chemical
toxicity (COMPACT) is one method for
revealing possible reasons for the toxicity of
a chemical because it calculates its three-
dimensional molecular structure and also
its electronic structure, and thus enables its
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metabolic activation by the cytochromes
P450 to be evaluated (1-4). Hence, toxic-
ity and in particular, carcinogenicity of a
chemical can be predicted (1-4). It is thus
more sophisticated than simply identifying
toxicophores by structure alert as in the
Hazardexpert system (5), although this is
useful for direct-acting agents, which are
not always recognized by the COMPACT
procedure. Furthermore, the influence of
substituents on the active moiety of the
chemical can be explored through molecu-
lar modeling techniques and quantitative
structure-activity relationships (QSARs);
these may augment or diminish the potency
ofa particular substituent and influence the
metabolic profile of the parent compound
(6-8). Investigation of the three-dimen-
sional structure enables differentiation
between structural isomers and facilitates
prediction of P450 specificity, in addition
to other, nongenotoxic, events such as
interaction with the peroxisome proliferator
and estrogen receptors (9,10).
The cytochromes P450 are a superfam-
ily of enzymes involved in the Phase 1
metabolism ofthe majority ofendogenous
and exogenous chemicals (1,11-13). It has
been established that many carcinogens act
as substrates and/or inducers for cyto-
chromes P4501A (CYPIA) (14-16) and
P4502E (CYP2E) (1,4,14), which give rise
to the formation of reactive intermediates,
or reactive oxygen species (ROS), capable
ofinteraction with DNA, causing miscod-
ing, mutagenesis, cell proliferation and
neoplasia (14). Inducers of CYPIA inter-
act with the cytosolic Ah receptor, initiat-
ing the protein kinase C cascade, de novo
synthesis of CYPIA, resulting in increased
carcinogen activation, increased DNA
replication, cell proliferation and malig-
nancy (14,15). Activation by CYP2E gives
rise to the production of ROS (17) and
reactive intermediates, causing many toxic
effects including cancer (14,18), especially
in small rodents which have high sensitiv-
ity to the toxicity of ROS. Although ROS
are carcinogenic per se (14) they may also
manifest carcinogenicity by oxygenation of
the chemical to a reactive intermediate
which subsequently interacts with DNA.
From analysis of a number of CYP2E-
specific chemicals of known toxicity/car-
cinogenicity, it is concluded that those
chemicals with AEvalues of < 15.0 are
more readily oxygenated and hence acti-
vated to proximate carcinogens while those
with higher AEvalues are not generally
activated but may exhibit other toxicity
associated with ROS generation.
From knowledge of the molecular and
electronic structures ofa chemical, its mol-
ecular dimensions (overallplanarity =
arealdepth2; collision diameter) and the
energy of activation (AE= E(HOMO) -
E(LUMO); LUMO = lowest unoccupied
molecular orbital, HOMO = highest occu-
pied molecular orbital) may be calculated.
From the known characteristics of area/
depth2, diameter, and AE, for known car-
cinogenic and noncarcinogenic substrates,
and for the active sites of different cyto-
chrome P450 isoforms, it is thus possible
to assign the chemical to the specific iso-
forms, CYPIA and CYP2E, which would
activate the chemical and hence determine
its potential carcinogenicity (1,11-14).
The technique of COMPACT (CYPlA
plus CYP2E) has been validated for 100
National Toxicology Program (NTP)
Environmental Health Perspectives - Vol 104, Supplement 5 * October 1996 1011LEWIS ETAL.
chemicals ofknown carcinogenicity, giving
a concordance with the rodent assay of
92% (19). In a subsequent validation
study of 44 NTP chemicals, containing
fewer positive carcinogens (60%) than the
first validation study, concordance of the
rodent assay with COMPACT (CYPIA
and CYP2E) was 72%, with Hazardexpert
was 70%, and with COMPACT plus
Hazardexpert was 86% (20).
The partition coefficient (log P) of a
chemical is an important mediating factor
for carcinogenic potential in that it deter-
mines accessibility of the chemical to the
activating enzyme, and there appears to be
a range oflog P values which constitute a
window of optimal transport properties
whereby a chemical can cross cellular
boundaries to enable interaction with the
P450 activating enzyme system, receptors
and DNA. Moreover, the rate of metabo-
lism ofmany chemicals has been related to
the magnitude of their log P values. The
Hazardexpert system (5) readily calculates
log P and other values, and in addition
offers structural alerts associated with car-
cinogenicity, mutagenicity, teratogenicity,
and other forms oftoxicity, such as neuro-
toxicity and immunotoxicity. Structure
alert programs make a useful complement
to COMPACT, in that direct-acting
agents, that might not normally be identi-
fied by COMPACT, are readily recognized
by Hazardexpert.
It has been shown that metal toxicity
in rodents correlates with the magnitude
of the metal ion redox potential (2) and
this provides a means of estimating the
potential carcinogenicity of metals and
their compounds. Possibly, some metal
toxicity is caused by the generation ofoxy-
gen radicals, and the redox potential repre-
sents a measure of the ability of the metal
to bring about activation of molecular
oxygen. The toxicity/carcinogenicity and
oxygen radical generation of Fe2+/Fe3+ is
well documented, and the redox potential
ofthis metal redox system (E°= +0.77V for
Fe2+/Fe3+) is taken as an index of likely
carcinogeniticy. If the redox potential is
high (usually positive) the indication of
acute toxicity is high.
This new series of 30 NTP chemicals
were thus evaluated for COMPACT
(CYPlA and CYP2E), for Hazardexpert,
and for metal ion redox potentials, and the
results considered in the light of muta-
genicity in Salmonella, in vivo cytogenetics,
and 90-day subchronic rodent pathology,
made available by NTP.
Methods
Molecular structural and electronic parame-
ters for COMPACT analysis were deter-
mined as previously described (3,12,16).
Criteria for P450 substrates were a high
degree of molecular planarity (ald2) and
high potential for activation by oxidative
metabolism (AE); the plot of aid2 against
AEgives a curve that separates CYP1 sub-
strates from non-CYPl substrates. The
radius of this curve (the COMPACT
radius, CR) is defined mathematically as:
CR = (AE -9.5)2+(aId2- 7.8)2;
substrates are positive for CYPI if the
COMPACT radius is < 5.5, and are
negative ifthe radius is >6.5A.
The criteria for CYP2E substrates that
have potential for ROS generation and oxi-
dation of the substrate are, empirically, a
molecular diameter of <6.5A, and a AE
value of < 15.0; all CYP2E substrates that
have been shown to be overtly toxic or car-
cinogenic have AEvalues of < 15.0. The
criteria for both CYPlA and CYP2E have
been slightly modified from previous
definitions as the COMPACT procedure
has been updated and refined (20).
Hazardexpert evaluations were made
using the standard software (version 6.1;
Compudrug Ltd., Budapest) (5).
Results
Only 5 ofthe 30 chemicals were identified
as potential CYP1 substrates, and hence as
potential carcinogens. Candidate chemicals
are potential CYP1 substrates if they are
planar (high values of area/depth2), and
have low values of AE, the activation
energy, that is, ifthe COMPACT radius is
< 5.5. Ofthe chemicals that are positive for
CYPI in COMPACT, no. 8 chloroprene
(COMPACT radius = 5.7), and no. 17,
xylenesulfonic acid CR = 6.0) are consid-
ered equivocally positive (±), and no. 25,
anthraquinone (CR = 4.3); no. 26, emodin
Table 1. COMPACT parameters for 30 chemicals.
Molecular Overallc
Area/ COMPACT CYPi collision CYP2Eb COMPACT
Chemical Depth2 AE(eV) radiusa interaction diameter activation prediction
1. Scopolamine 1.6 15.4 8.6 - 7.9
2. Codeine 1.4 14.1 7.9 - 8.1
3. 1,2-Dihydro-2,2,4- 1.8 13.1 7.0 - 6.9
trimethylquinoline
4. Nitromethane 1.4 14.8 8.3 - 4.7 + +
5. Tetrahydrofuran 1.6 20.9 13.0 - 5.1 - -
6. t-Butylhydroquinone 1.8 14.3 7.7 - 6.7
7. Ethylbenzene 2.1 16.7 9.2 - 6.0
8. Chloroprene 3.7 13.5 5.7 ± 5.3 + +
9. Cobalt sulfate NP NP NP NP NP NP NP
10. D&CYellow No. 11 2.0 13.0 6.8 - 7.8
11. Isobutyraldehyde 1.5 17.5 10.2 - 5.3
12. Molybdenum trioxide NP NP NP NP NP NP NP
13. 1-Chloro-2-propanol 1.5 16.4 9.3 - 5.3 - -
14. Diethanolamine 2.9 20.3 11.9 - 5.8 - -
15. Phenolphthalein 2.0 13.9 7.3 - 8.1 - -
16. Pyridine 4.3 16.2 7.6 - 5.2 - -
17. Xylenesulfonic acid 3.7 13.9 6.0 + 6.7 - +
18. Furfuryl alcohol 2.6 15.3 7.8 - 5.4 + +
19. Primaclone 1.7 15.9 8.8 - 7.3
20. Ethylene glycol 3.3 20.5 11.9 - 6.4
monobutyl ether
21. Gallium arsenide NP NP NP NP NP NP NP
22. Isobutene 2.3 17.9 10.0 - 5.1 -
23. Methyleugenol 1.8 14.8 8.0 - 7.1 -
24. Oxymetholone 2.7 13.9 6.7 - 8.5 -
25. Anthraquinone 9.4 13.5 4.3 + 7.0 - +
26. Emodin 6.6 12.3 3.1 + 7.5 - +
27. Citral 1.5 14.2 7.9 - 6.8 -
28. Sodium nitrite NP NP NP NP NP NP NP
29. Cinnamaldehyde 6.9 13.3 3.9 + 6.2 + +
30. Vanadium pentoxide NP NP NP NP NP NP NP
Abbreviations: NP, not predicted; +, positive; -, negative. 8COMPACT radius, V(AE -9.5)2 +(a/d2 -7.8)2 Positive
CYP1 if COMPACT radius <5.5; ± if radius is between 5.5 and 6.5. bCYP2E activation, molecular collision diameter
<6.5 and AE< 15.0. cOverall COMPACT prediction is the summation of CYP1 interaction and CYP2E activation.
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(CR = 3.1); and no. 29, cinnamaldehyde
(CR = 3.9) are considered firmly positive
(+) (Table 1).
In the COMPACT evaluation for
potential CYP2E-activating substrates,
criteria for positive chemicals were, molec-
ular collision diameter <6.5 A and AE of
< 15.0. Three chemicals were rated positive
for CYP2E, namely, no. 4, nitromethane
(diam = 4.7, AE= 14.8); no. 8, chloro-
prene (diam = 5.3, AE= 13.5); and no. 29,
cinnamaldehyde (diam = 6.2, AE = 13.3)
(Table 1). Furfuryl was considered equivo-
cal for CYP2E (diam = 5.4, AE 15.3).
Only two chemicals were positive for both
CYP1 and CYP2E: chloroprene and cin-
namaldehyde, although chloroprene is only
equivocally positive for CYP1.
In the Hazardexpert predictions (Table
2) four chemicals were identified as poten-
tial carcinogens: scopolamine (no. 1),
D & C Yellow no. 11 (no. 10), citral (no.
27), and cinnamaldehyde (no. 29); five
chemicals were identified as potential
mutagens: tetrahydrofuran (no. 5), t-butyl-
hydroquinone (no. 6), 1-chloro-2-pro-
panol (no. 13), phenolphthalein (no. 15),
and emodin (no. 26). Only cinnamalde-
hyde was positive in all 3 segments, CYPI
and CYP2E of COMPACT, and the
Hazardexpert prediction.
Supplemental Information on the
ChemicalsTestedbyNumber
1. Scopolamine. This compound, a
hypnotic and an anesthetic, is negative in
all segments of COMPACT, but Hazard-
expert regards this as a probable carcinogen
due to its epoxide group. The chemical is
structurally similar to cocaine which is
metabolized by P450 to form an N-oxide,
and also a nitroxide via N-demethylation
and N-hydroxylation, and is therefore
likely to be detoxicated (21). Scopolamine
was negative in the Salmonella assay, and
we therefore regard this chemical as a non-
carcinogen. Scopolamine showed no evi-
dence of potential carcinogenicity in a
90-day subchronic rodent toxicity study.
2. Codeine. COMPACT in both seg-
ments (CYPI and CYP2E) is negative for
this compound, and Hazardexpert only
regards this chemical as an uncertain ter-
atogen; carcinogenicity is therefore most
unlikely. In a 90-day rodent toxicity study
no evidence of toxicity or carcinogenicity
was seen.
3. 1,2-Dihydro-2,2,4-trimethylquino-
line. This chemical is an antioxidant. It is
negative in COMPACT; Hazardexpert is
also negative and the short-term tests
Table 2. Hazardexpert predictions for 30 chemicals.
Prediction of
No. Chemical Log P Toxicity carcinogenicity
1. Scopolamine 2.09 Carcinogen +
2. Codeine 2.40 Teratogen
3. 1,2-Dihydro-2,2,4-trimethyl 3.77 -
quinoline
4. Nitromethane -0.24 -
5. Tetrahydrofuran 0.50 Mutagena
6. t-Butylhydroquinone 3.05 Mutagen
7. Ethylbenzene 3.06 --
8. Chloroprene 1.88 -
9. Cobaltsulfate NP NP
10. D&C Yellow No. 11 1.96 Carcinogen +
11. Isobutyraldehyde 0.57
12. Molybdenum trioxide NP NP
13. 1-Chloro-2-propanol 0.13 Teratogen and mutagen -
14. Diethanolamine -2.73 Teratogen
15. Phenolphthalein 4.53 Mutagen
16. Pyridine 0.74 --
17. Xylenesulfonic acid 2.81 -
18. Furfuryl alcohol 0.21 -
19. Primaclone -1.17 -
20. Ethylene glycol butyl ether 0.22 Teratogen
21. Gallium arsenide NP NP
22. Isobutene 2.08 -
23. Methyleugenol 3.35 Teratogen
24. Oxymetholone 4.18 Teratogen
25. Anthraquinone 2.54 -
26. Emodin 1.49 Mutagen
27. Citral 3.24 Carcinogen +
28. Sodium nitrite NP NP
29. Cinnamaldehyde 1.92 Carcinogen +
30. Vanadium pentoxide NP NP
Abbreviations: NP, no prediction; +, positive; -, negative. "Not in mammalia.
(micronucleus and mutagenicity) are both
negative. The overall prediction for car-
cinogenicity is therefore negative. A 90-day
skin-painting study showed no evidence of
carcinogenicity, although acanthoses and
hyperkeratoses were observed in both sexes
ofrat and mouse.
4. Nitromethane. COMPACT indi-
cates possible carcinogenicity via CYP2E
activation for this chemical. Hazardexpert
does not give any indication of toxicity, as
the nitro group is in an aliphatic position;
it is also negative in the Ames test and in
the micronucleus test. The negative log P
value (-0.24) indicates that the chemical
would be insufficiently lipophilic to reach
the cytochrome P450 enzymes. The overall
prediction is therefore that the chemical is
a weak rodent carcinogen. A 90-day rodent
toxicology study shows increased bone-
marrow cellularity in rat and increased
splenic haematopoiesis in mouse, indicat-
ing possible weak rodent carcinogenicity as
predicted by COMPACT.
5. Tetrahydrofuran (THF). Although
a possible CYP2E substrate, this chemical
is unlikely to be activated (AE = 20.9) and
consequently is considered to be negative
in COMPACT. Hazardexpert shows this
chemical to be a mutagen, but not in
mammalian systems. THF was negative in
the Ames and micronucleus tests, and so is
predicted to be noncarcinogenic. A 90-day
rodent study showed no evidence ofpoten-
tial carcinogenesis although slight cen-
trilobular hepatic cytomegaly was seen in
the mouse.
6. t-Butylhydroquinone. COMPACT
is negative for both CYPI and CYP2E for
this chemical, but Hazardexpert indicates
possible mutagenicity due to the phenolic
groups. t-Butylhydroquinone has the
potential for redox cycling, and hydro-
quinone itself is a known carcinogen.
Structurally, the compound resembles
butylated hydroxytoluene (BHT) an equiv-
ocal rodent carcinogen. However, the
Ames test and in vivo cytogenetic studies
are both negative, so there is no firm evi-
dence for carcinogenicity. A 90-day rodent
feeding study also showed no evidence of
potential carcinogenicity.
7. Ethylbenzene. COMPACT gives no
indication of potential carcinogenicity,
Hazardexpert does the same. With the neg-
ative evidence from the short-term Ames
Environmental Health Perspectives
- Vol 104, Supplement 5 * October 1996 1013LEWIS ETAL.
and cytogenicity tests, it is evident that
ethylbenzene will be noncarcinogenic in
rodents. A 90-day inhalation study in
rodents showed no evidence of toxicity,
although increased tumor formation has
been reported following gavage to rats.
8. Chloroprene. This chemical,
although equivocal (±) in the COMPACT
CYP1 evaluation, is a clear positive in
COMPACT for CYP2E specificity and
activation, and therefore is predicted as a
positive carcinogen by COMPACT.
Hazardexpert identifies no toxicophores in
the structure, and the chemical is negative
in the short-term Ames and cytogenetics
tests, although it is hepatotoxic. Chloro-
prene may form a cysteine conjugate,
which could be activated via P-lyase-medi-
ated cleavage of the cysteine conjugate, a
known mechanism for carcinogenicity. By
analogy with vinyl chloride, this chloro-
alkene would seem likely to be carcino-
genic, and our overall prediction is that it
would be positive. However, no evidence
of potential carcinogenicity was obtained
in the rodent 90-day study.
9. Cobalt Sulfate. As this is an inor-
ganic compound, its carcinogenicity could
not be predicted by the COMPACT and
Hazardexpert systems. However, from the
relatively low redox potential for Co/Co2 ,
(E°=-0.28V), carcinogenicity is unlikely.
Many studies on cobalt compounds show
them to be noncarcinogenic, and even
antimutagenic. However, the 90-day
rodent study showed inflammatory, meta-
plastic, and hyperplastic changes, but no
evidence offrank carcinogenicity.
10. D &- C YeUlow No. 11. This com-
pound is negative in COMPACT, but
Hazardexpert predicts that it is likely to be
both carcinogenic and mutagenic and
there is evidence for the latter in the Ames
study. Although negative in COMPACT,
the prediction of carcinogenicity by
Hazardexpert, and the positive Ames test
give an overall positive prediction. The
molecule may interact directly with DNA
as seen with phenytoin, although this may
occur with only one of its enantiomers.
A 90-day rat study showed periportal
hepatocyte degeneration, but no evidence
ofcarcinogenicity.
11. Isobutyraldebyde. This compound
is negative in both COMPACT and
Hazardexpert, as well as in the Ames and
micronucleus tests. The overall prediction
for carcinogenicity is therefore negative.
From a rat subchronic inhalation study,
there is evidence ofupper respiratory lesions
but no evidence ofpotential carcinogenicity.
12. Molybdenum Trioxide. This is an
inorganic compound that could not be
evaluated by COMPACT or Hazardexpert.
There is no evidence ofpotential carcino-
genicity from the short-term test data, but
the Mo3+/Mo4+ redox potential is relatively
high (E° = +0.32 V), indicating an oxidiz-
ing agent, and potential for carcinogenic-
ity. However, the low solubility of the
compound may preclude hazardous effects,
so it is considered a potential weak carcino-
gen. A 90-day rodent study showed no
evidence ofpotential carcinogenicity.
13. 1-Chloro-2-propanol. COM-
PACT is negative for both CYP1 and
CYP2E. Hazardexpert predicts teratogenic-
ity, based on the chloroethyl moiety, and
the strongly electrophilic 2-carbon could
indicate a direct-acting carcinogen. The
Ames test is positive, and our prediction is
that the chemical is likely to be weakly car-
cinogenic. The 90-day rodent studyshowed
no evidence ofpotential carcinogenicity.
14. Diethanolamine. This chemical is
negative in COMPACT for both CYP1
and CYP2E. Hazardexpert shows weak
teratogenicity based on the hydroxyethyl
group, but carcinogenicity is unlikely.
Diethanolamine is negative in the Ames and
micronucleus tests, the overall prediction for
carcinogenicity is therefore negative. The
rodent subchronic toxicity study showed no
evidence ofpotential carcinogenicity.
15. Phenolphthalein. COMPACT
shows this compound to be negative for
P450-mediated toxicity. Hazardexpert,
however, suggests possible mutagenicity.
The chemical is positive in the micronu-
cleus test and negative in the Ames test.
The overall prediction is therefore negative.
A rodent 90-day feeding study showed no
evidence ofpotential carcinogenicity.
16. Pyridine. The chemical is negative
in COMPACT for both CYPI and
CYP2E; Hazardexpert also predicts no tox-
icity. Both the Ames and micronucleus
tests were negative. The overall prediction
is therefore negative. The 90-day sub-
chronic study showed liver lesions in
female rats, while males showed both liver
and kidney lesions. However, no evidence
ofpotential carcinogenicity was seen.
17. XylenesulfonicAcid. This chemical
is weakly positive in COMPACT for
CYP1 and negative for CYP2E; however,
Hazardexpert gives no indication oftoxic-
ity. Evidence from short-term test data,
and the likelihood of rapid elimination
due to the presence of the sulphonic acid
group, support the view that this chemical
is not likely to be a rodent carcinogen,
and the overall prediction for carcinogenic-
ity is therefore negative. The 90-day skin-
painting study showed no evidence of
potential carcinogenicity.
18. FurfurylAlcohol COMPACT for
CYPI is negative and for CYP2E is equivo-
cal; Hazardexpert gives no indication of
toxicity. The Ames and micronucleus tests
are both negative; the overall prediction for
carcinogenicity is therefore equivocal. A
90-day rodent inhalation study showed
metaplasia and hyperplasia ofthe respira-
tory epithelium; 2-year carcinogenicity
studies on the related compounds, furan
and furfural showed that these chemicals
were carcinogenic in liver ofrats and mice.
19. Primaclone. This chemical is nega-
tive in both CYPI and CYP2E segments of
COMPACT, and Hazardexpert gives no
evidence oftoxicity. The chemical is con-
sidered negative in the Ames (although
positive without S9 mix) and micronucleus
tests, and the overall prediction is therefore
negative. The 90-day rodent study showed
hepatocellular hypertrophy, but no evidence
ofcarcinogenicity.
20. Ethylene GlycolMonobutylEther.
This chemical is negative in both CYPI
and CYP2E segments of COMPACT;
Hazardexpert also predicts that it will be a
teratogen but noncarcinogenic, and there is
no evidence ofpotential genotoxicity from
the in vitro data; so although the overall
prediction for carcinogenicity is negative,
this compound, being a glycol ether, is
likely to be overtly toxic. The 90-day
rodent study showed evidence of inflam-
mation, and hepatic and gastric necrosis,
but no frank carcinogenesis.
21. Gallium Arsenide. As this chemi-
cal is inorganic, it cannot be evaluated via
the COMPACT and Hazardexpert proce-
dures. The Ames and micronucleus tests are
negative. The redox potential for Ga/Ga3+
is low (E° = -0.56V) but for As/AsO2- is
high (E° = +0.25V), indicating a likelihood
ofcarcinogenicity. The 90-day rodent study
showed inflammatory lesions, hyperplasia,
and metaplasia in both rats and mice,
indicative ofpotential carcinogenicity.
22. Isobutene. This chemical is nega-
tive in both CYPI and CYP2E segments of
COMPACT; and Hazardexpert does not
indicate any toxicity, although by analogy
with butadiene it can be considered a sus-
pect carcinogen. TheAmes test was negative,
so the overall prediction for carcinogenesis
is negative. A 90-day inhalation study gave
no indication ofpotential carcinogenicity.
23. Methyl Eugenol. COMPACT
gives no evidence ofcarcinogenicity for this
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compound and this is in agreement with
the Hazardexpert evaluation. There is
support for these findings in the in vitro
test data, and although methyl eugenol is
structurally related to safrole, a known car-
cinogen, the overall prediction for carcino-
genicity is negative. A rodent 90-day study
showed no evidence ofcarcinogenicity.
24. Oxymetholone. Negative in both
segments of COMPACT, this compound
is also considered to be noncarcinogenic by
Hazardexpert, although there is indication
ofpossible teratogenicity. The compound
is not mutagenic in the Ames test so the
overall prediction for carcinogenicity is
negative. A 90-day study shows no evi-
dence of carcinogenicity, but published
data indicate that this anabolic steroid is a
promoter ofrat liver carcinogenesis.
25. Anthraquinone. This chemical is
highly planar and is positive for CYP1 in
COMPACT but negative for CYP2E.
Hazardexpert does not predict carcino-
genicity, but the molecule may be reduced
and generate ROS by redox cycling; it
exhibits mutagenicity in the Ames test. The
prediction for COMPACT is positive, and
the overall prediction for potential carcino-
genicity is weakly positive. No subchronic
rodent studies has yet been completed.
26. Emodin. Emodin is positive for
CYP1 in COMPACT, whereas Hazard-
expert predicts only mutagenicity. There is
evidence for mutagenicity from the Ames
and micronucleus tests, and it is known
that hydroxyanthraquinones are also tumor
promoters. However, this hydroxylated
anthraquinone will be detoxicated by con-
jugation. The COMPACT prediction for
emodin is positive, and the overall predic-
tion for carcinogenicity is weakly positive,
because ofprobable detoxication by conju-
gation. A 90-day rodent study showed
hyperplasia but no tumorigenesis.
27. Citral This compound is negative
in both segments (CYP1 and CYP2E) of
COMPACT, but it is known to be a weak
peroxisome proliferator and CYP4 inducer.
Hazardexpert flags potential carcinogenic-
ity due to the ax4-unsaturated aldehyde
function, but the Ames and cytogenetics
tests are negative. The overall prediction
for carcinogenicity is negative. No 90-day
rodent studies have yet been completed.
28. Sodium Nitrite. This cannot be
evaluated by COMPACT as it is inorganic.
The sodium ion is unlikely to be toxic, but
the nitrite ion would readily give rise to the
formation of nitrosamines in the gut,
which may explain the indication of
mutagenicity from the Ames test. As
nitrosamines are markedly carcinogenic in
rodents, the overall prediction for carcino-
genicity is positive. A 90-day rodent study
showed squamous epithelial hyperplasia of
the forestomach.
29. Cinnamaldehyde. This chemical is
predicted to be potentially carcinogenic by
both CYPI and CYP2E segments of
COMPACT, and by Hazardexpert. There
are no mutagenicity data, however, previ-
ous studies have shown that this com-
pound is both mutagenic and carcinogenic
(22), in agreement with the COMPACT
and Hazardexpert predictions. The overall
prediction ofcarcinogenicity is positive. A
90-day rodent gavage study showed hyper-
plasia ofthe forestomach, but no evidence
ofmalignancy.
30. Vanadium Pentoxide. COMPACT
and Hazardexpert evaluations cannot be
made on this inorganic compound; the
Ames and cytogenetics tests were negative.
The redox potential ofV2+/V3+ is high (E°
= +0.36 V) indicating possible carcinogen-
esis. The overall prediction for carcino-
genicity is positive. A rodent 90-day study
showed epithelial hyperplasia, metaplasia,
and inflammation but no tumorigenesis.
A summary of the predictions of
COMPACT, the Ames and micronucleus
tests, the redox potential of metals and
Hazardexpert is presented in Table 3. In
the overall prediction (Table 3), all predic-
tion parameters (COMPACT, Ames,
micronucleus, redox potential, Hazard-
expert) are considered. The number of
chemicals predicted positive for carcino-
genicity is 12 of30, ofwhich 6 of30 were
positive in COMPACT, 3 of 30 were
metal compounds considered positive for
potential carcinogenicity from their metal
ion redox potentials, and 3 of 30 (D&C
Yellow No. 11, 1-chloro-2-propanol, and
sodium nitrite) were considered positive
from their mutagenicity in the Ames test,
Hazardexpert, and published data.
Table 3. Summarized COMPACT and other predictions for 30 chemicals.
Redox In vivo Hazard Overalla
No. Compound COMPACT potential Ames cytogenetics expert prediction
1. Scopolamine +
2. Codeine - - - - - -
3. 1,2-Dihydro-2,2,4-trimethyl - - - - - -
quinoline
4. Nitromethane + - - - - +
5. Tetrahydrofuran
6. t-Butylhydroquinone
7. Ethylbenzene
8. Chloroprene + - - - - +
9. Cobalt sulfate NP - - - NP
10. D&CYellow No. 11 - - + - + +
11. Isobutyraldehyde
12. Molybdenum trioxide NP + - - NP +
13. 1-Chloro-2-propanol - - + - - +
14. Diethanolamine -
15. Phenolphthalein - - - +
16. Pyridine -
17. Xylenesulfonic acid +
18. Furfuryl alcohol + - - - - +
19. Primaclone _ _ +b
20. Ethylene glycol butyl ether
21. Gallium arsenide NP + + - NP +
22. Isobutene
23. Methyleugenol
24. Oxymetholone - - - - - -
25. Anthraquinone + - + - - +
26. Emodin + - + + - +
27. Citral - - - - +
28. Sodium nitrite NP - + - NP +
29. Cinnamaldehyde + - + - + +
30. Vanadium pentoxide NP + - - NP +
Positive responses (n) 7/30 3/30 7/30 2/30 4/30 12/30
NP, no prediction; +, positive; -, negative; ±, equivocal in COMPACT and weakly positive in the overall prediction.
"Overall prediction is based primarily on the compact data, taking into consideration the lipophilicity of the chemi-
cal and likely rate of elimination. For compounds that are probably direct acting, predictions by Hazardexpert were
given prominence, although pathways to detoxication are also taken into account. bAlthough positive without acti-
vation, this chemical gave a negative response with the S9 mix.
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Those chemicals with overall predic-
tion of potential carcinogenicity (12 of
30) are nitromethane (no. 4), chloroprene
(no. 8), D&C Yellow No. 11 (no. 10),
molybdenum trioxide (no. 12), 1-chloro-
2-propanol (no. 13), furfuryl alcohol (no.
18), gallium arsenide (no. 21), anthra-
quinone (no. 25), emodin (no. 26),
sodium nitrite (no. 28), cinnamaldehyde
(no. 29), and vanadium pentoxide (no.
30). Those positive in COMPACT were
nos. 4, 8, 17, 18, 25, 26, and 29; those
positive by metal ion redox potential were
nos. 12, 21, and 30.
Although we are primarily concerned in
the identification ofpotential carcinogens,
the use of COMPACT to identify sub-
strates of CYPIA and/or CYP2E enables
prediction ofovert toxicity in addition to
carcinogenicity, as the reactive intermedi-
ates so formed may give rise to covalent
complexes with protein and RNA, as well
as with DNA, and may thus initiate
immunotoxicity, which can often prove
fatal. The supplementation ofCOMPACT
to include metals, by prediction ofpoten-
tial carcinogenicity from redox potentials
and the likelihood ofoxygen radical gener-
ation, together with a combination with
Hazardexpert and short-term mutagenicity
tests, considerably widens the scope of
COMPACT predictions to include toxic
metals, direct-acting carcinogens, and
chemicals that effect malignancy by mecha-
nisms other than interaction ofDNA with
reactive intermediates or oxygen radicals.
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